R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Medical Advisor - Nordics

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • An MD, PharmD, or PhD is required; oncology experience is strongly preferred.
  • At least 8 years of experience in Medical Affairs or related functions in the pharmaceutical or biotech industry is required.
  • Strong understanding of oncology clinical development, evidence generation, and the treatment landscape is required.
  • Ability to interpret and communicate complex scientific and clinical data is required.
  • Experience engaging with healthcare professionals, academic researchers, and medical societies is required.
  • Fluency in one or more Nordic languages and English, written and spoken, is required.
  • Ability to work effectively in a matrixed, cross-functional, and multicultural environment is required.
  • Willingness to travel within the Nordics and internationally up to 30% is required.

Responsibilities

  • Co-develop and implement an early pre-launch Nordics Medical Affairs strategy and tactical plan for assigned products and therapeutic areas.
  • Establish and maintain trusted scientific relationships with key opinion leaders, investigators, and healthcare professionals across the Nordics.
  • Provide medical oversight and scientific input to cross-functional teams, ensuring alignment with regulatory and compliance standards.
  • Collaborate with Medical Science Liaisons, Medical Affairs, and clinical research departments to support scientific exchange, education, and data dissemination activities across the Nordics region.
  • Contribute medical input to promotional and non-promotional materials, internal training, and advisory boards.
  • Plan and execute national medical meetings, symposia, and congress participation to enhance scientific visibility.
  • Support investigator-initiated trials and local clinical research activities in collaboration with global and regional teams.
  • Monitor the competitive and scientific landscape to inform internal strategy and provide actionable medical insights.
  • Partner with HEOR and market access to develop real-world evidence and outcomes research projects.
  • Ensure compliance with Nordic countries' and EU regulatory frameworks governing interactions with healthcare professionals.
  • Collaborate with Clinical Operations and CROs on site selection, Site Initiation Visits, and investigator engagement.

Desired Qualifications

  • Prior experience in oncology product launches.
  • A strong network within the Nordics oncology community.
  • Experience in investigator-initiated or real-world evidence studies.
  • Knowledge of healthcare systems, reimbursement structures, and compliance requirements in the Nordic countries.
  • A track record in publication planning, congress presentations, and scientific communications.
  • Oncology experience.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs